From: The European challenges of funding orphan medicinal products
Austrial | Belgium | Bulgariam | Czech Republicn | Hungary | Poland | Slovenia | |
---|---|---|---|---|---|---|---|
2013 | |||||||
Total public expenditure on OMPs in local currency | 98,600,000 €a | 245,000,000 €b | 16,201,220 BGNc | 1,100,000,000 CZKd | 9,577,605,323 HUFe | 212,725,536 PLNf | 16,893,308 €g |
Eurostat exchange rate - annual data (/1 €) | 1.96 BGNh | 25.98 CZKh | 296.87 HUFh | 4.20 PLNh | |||
Total public expenditure on OMPs in € | 98,600,000 | 245,000,000 | 8266,000 | 42,340,000 | 32,262,000 | 50,649,000 | 16,893,000 |
Size of population | 8,500,000j | 11,161,642i | 7,284,552i | 10,516,125i | 9,908,798i | 38,062,535i | 2,058,821i |
Total public expenditure on OMPs in €/capita | 11.60 | 21.95 | 1.13 | 4.03 | 3.26 | 1.33 | 8.21 |
2014 | |||||||
Total public expenditure on OMPs in local currency | 109,800,000 €a | 280,000,000 €b | 23,967,183 BGNc | 1,400,000,000 CZKo | 12,501,994,171 HUFe | 348,368,792PLNf | 19,853,716 €g |
Eurostat exchange rate - annual data (/1 €) | 1.96 BGNh | 27.54 CZKh | 308.71 HUFh | 4.18 PLNh | |||
Total public expenditure on OMPs in € | 109,800,000 | 280,000,000 | 12,228,000 | 50,835,000 | 40,496,000 | 83,342,000 | 19,854,000 |
Size of population | 8,500,000k | 11,180,840i | 7,245,677i | 10,512,419i | 9,877,365i | 38,017,856i | i2,061,085 |
Total public expenditure on OMPs in €/capita | 12.92 | 25.04 | 1.69 | 4.84 | 4.10 | 2.19 | 9.63 |
Average of total expenditure on OMP in €/capita in 2013 and 2014 | 12.26 | 23.50 | 1.41 | 4.43 | 3.68 | 1.76 | 8.92 |